1/37
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
screening
Ultrasound falls under what type of test?
screening
Maternal serum marker screening falls under what type of test?
screening
Non-invasive prenatal testing (NIPT) falls under what type of test?
diagnostic
Chorionic villus sampling (CVS) falls under what type of test?
diagnostic
Amniocentesis falls under what type of test?
both 1st and 2nd trimester
during what trimester can you perform a blood screening?
both 1st and 2nd trimester
during what trimester can you perform a non-invasive prenatal testing?
1st trimester
during what trimester can you perform a nuchal translucency ultrasound?
2nd trimester
during what trimester can you perform a fetal survey ultrasound?
1st trimester
during what trimester can you perform a chorionic villus sampling (CVS)?
2nd trimester
during what trimester can you perform an amniocentesis test?
11-13+ weeks
when is a nuchal translucency screening performed?
Nuchal Translucency Ultrasound
Test:
Measures nuchal translucency: fluid under the skin behind the fetal neck?
Nuchal Translucency Ultrasound
identify the test:
18-22 weeks
when is a fetal anatomic survey performed?
Fetal Anatomic Survey
Test:
•Can detect structural fetal anomalies such as congenital heart defects
•Can detect "soft markers" for aneuploidy such as echogenic intracardiac foci
Fetal Anatomic Survey
identify the test that can survey for this heart defect:
Maternal Serum Marker Screening
Test:
-Measurement of proteins and hormones produced by the fetus and placenta, circulating in maternal blood
Maternal Serum Marker Screening
Test:
•Can evaluate the chances for Down syndrome, trisomy 18, and open neural tube defects
11-13+ weeks
when is the 1st trimester Maternal Serum Marker Screening performed?
15-21 weeks
when is the 2nd trimester Maternal Serum Marker Screening performed?
Non-invasive prenatal testing (NIPT)
Test:
Evaluation of cell-free DNA in maternal serum
•Can evaluate the chances for trisomies 21, 18, 13, monosomy X in the fetus/placenta
•Significantly higher detection rates and lower false positive rates than traditional maternal serum marker screening
Nuchal Translucency Ultrasound
results from a material serum marker can be combined with what test for a better prediction?
anytime after 10 weeks
when is a Non-invasive prenatal testing (NIPT) performed?
13, 18, 21
a fetus with a trisomy can survive if it occurs at what 3 chromosomes?
10-13 weeks
when is a fetal anatomic survey performed?
15+ weeks
when is an amniocentesis test performed?
Pre-Implantation Genetic Screening (PGS)
Test:
•Embryos obtained through an in vitro fertilization cycle can be screened for aneuploidy or single gene disorders
•Embryos grow into a multi-cell state then biopsied for testing
false
t/f: Pre-implantation genetic screening can be used diagnostically to determine chance of aneuploidy
true
t/f: Pre-implantation genetic "diagnosis" is not a diagnostic test
Pre-implantation genetic "diagnosis" (PGD)
Test:
-typically uses a family-specific test to screen for a single gene disorder in embryos
-Offered to couples at increased risk for a single gene disorder
-A family-specific molecular test is developed for each couple
trisomy 21
The Amniocentesis and FISH result shows as following. What is the most likely possible karyotype?
Red: chromosome 21
Yellow: chromosome 14
Green: chromosome 12
severe combined immunodeficiency disease (SCID)
•Caused by mutation in ADA gene coding for the blood enzyme adenosine deaminase
germline therapy
gene therapy involving corrected nuclear transfer
false
t/f: both somatic and germline therapy are approved in the US
true
t/f: Most fetuses with an increased nuchal translucency do not have aneuploidy
FISH or karyotype analysis
what two tests are mostly used on the results of a CVS or amniocentesis sample?
3
oA nuchal translucency measurement of >__ mm is associated with an increased risk for aneuploidy and fetal heart defects